Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
BCPC

BCPC - Balchem Corp Stock Price, Fair Value and News

172.14USD-1.89 (-1.09%)Market Closed

Market Summary

BCPC
USD172.14-1.89
Market Closed
-1.09%

BCPC Stock Price

View Fullscreen

BCPC RSI Chart

BCPC Valuation

Market Cap

5.6B

Price/Earnings (Trailing)

48.61

Price/Sales (Trailing)

6

EV/EBITDA

31.1

Price/Free Cashflow

30.61

BCPC Price/Sales (Trailing)

BCPC Profitability

Operating Margin

33.39%

EBT Margin

15.60%

Return on Equity

10.64%

Return on Assets

7.23%

Free Cashflow Yield

3.27%

BCPC Fundamentals

BCPC Revenue

Revenue (TTM)

929.6M

Rev. Growth (Yr)

3.06%

Rev. Growth (Qtr)

4.79%

BCPC Earnings

Earnings (TTM)

114.8M

Earnings Growth (Yr)

27.64%

Earnings Growth (Qtr)

8.77%

Breaking Down BCPC Revenue

Last 7 days

3.7%

Last 30 days

12.9%

Last 90 days

20.0%

Trailing 12 Months

30.9%

How does BCPC drawdown profile look like?

BCPC Financial Health

Current Ratio

2.61

Debt/Equity

0.14

Debt/Cashflow

1.17

BCPC Investor Care

Shares Dilution (1Y)

0.61%

Diluted EPS (TTM)

3.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024929.6M000
2023946.0M940.6M926.3M922.4M
2022842.2M876.6M923.0M942.4M
2021714.9M743.9M766.6M799.0M
2020661.1M672.9M689.5M703.6M
2019639.3M637.2M640.7M643.7M
2018618.5M635.1M639.4M643.7M
2017555.8M564.1M576.3M594.8M
2016542.8M546.8M545.2M553.2M
2015600.3M602.8M582.4M552.5M
2014338.5M387.5M460.3M541.4M
2013318.8M323.1M335.6M337.2M
2012295.1M299.4M300.1M310.4M
2011268.2M281.4M291.9M291.9M
2010228.3M237.3M246.2M255.1M
2009000219.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Balchem Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 10, 2024
sestrick michael robert
sold
-297,935
154
-1,929
svp & chief technology officer
May 08, 2024
fischer david b
sold
-764,902
152
-5,000
-
Mar 08, 2024
tignor michael brent
acquired
358,680
85.4
4,200
svp & chief hr officer
Mar 08, 2024
tignor michael brent
sold
-840,985
157
-5,339
svp & chief hr officer
Mar 04, 2024
wineinger matthew david
sold
-209,128
156
-1,333
-
Feb 26, 2024
backus william a.
sold
-1,086,300
155
-7,000
vp & chief accounting officer
Feb 23, 2024
backus william a.
acquired
738,421
80.438
9,180
vp & chief accounting officer
Feb 23, 2024
backus william a.
sold
-1,435,470
156
-9,180
vp & chief accounting officer
Feb 22, 2024
harris theodore l
sold
-5,300,030
154
-34,350
chairman, president & ceo

1–10 of 50

Which funds bought or sold BCPC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 19, 2024
NISA INVESTMENT ADVISORS, LLC
reduced
-2.02
-22,977
841,799
-%
Jul 19, 2024
First Horizon Advisors, Inc.
unchanged
-
-432
66,506
-%
Jul 19, 2024
Sumitomo Mitsui Trust Holdings, Inc.
reduced
-14.95
-435,819
2,376,990
-%
Jul 19, 2024
Continuum Advisory, LLC
unchanged
-
-2.00
308
-%
Jul 19, 2024
RAYMOND JAMES & ASSOCIATES
added
1.88
93,290
7,751,060
-%
Jul 19, 2024
Zhang Financial LLC
unchanged
-
-5,000
769,750
0.05%
Jul 18, 2024
Assenagon Asset Management S.A.
reduced
-5.49
-1,206,780
18,563,900
0.04%
Jul 18, 2024
Portside Wealth Group, LLC
new
-
212,297
212,297
0.04%
Jul 18, 2024
Triad Wealth Partners, LLC
new
-
2,309
2,309
-%
Jul 18, 2024
Blue Trust, Inc.
added
465
14,410
17,509
-%

1–10 of 50

Are Funds Buying or Selling BCPC?

Are funds buying BCPC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BCPC
No. of Funds

Unveiling Balchem Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.76%
3,791,512
SC 13G/A
Feb 09, 2024
wasatch advisors lp
-
0
SC 13G/A
Feb 07, 2024
apg asset management us inc.
9.0%
2,917,112
SC 13G/A
Jan 22, 2024
blackrock inc.
15.5%
4,989,247
SC 13G/A
Feb 09, 2023
wasatch advisors inc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
11.95%
3,841,468
SC 13G/A
Jan 26, 2023
blackrock inc.
15.5%
4,972,536
SC 13G/A
Jan 20, 2023
blackrock inc.
15.5%
4,972,536
SC 13G/A
Jan 12, 2023
apg asset management us inc.
8.5%
2,719,969
SC 13G/A
Feb 11, 2022
wasatch advisors inc
-
0
SC 13G

Recent SEC filings of Balchem Corp

View All Filings
Date Filed Form Type Document
Jun 24, 2024
8-K
Current Report
Jun 18, 2024
11-K
Employee Benefit Details
May 24, 2024
144
Notice of Insider Sale Intent
May 21, 2024
144
Notice of Insider Sale Intent
May 13, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
144
Notice of Insider Sale Intent
May 08, 2024
144
Notice of Insider Sale Intent
May 03, 2024
8-K
Current Report
May 03, 2024
10-Q
Quarterly Report

Peers (Alternatives to Balchem Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
58.5B
12.2B
-4.32% -12.78%
23.68
4.81
-7.47% 13.44%
38.0B
43.5B
-2.78% 1.60%
29.92
0.87
-18.61% -57.39%
15.2B
10.7B
-0.16% 13.92%
7.62
1.42
7.11% 34.19%
14.2B
6.9B
-3.43% -3.25%
54.47
2.06
-6.48% -57.90%
11.4B
9.1B
-1.89% 10.90%
12.35
1.25
-11.38% 33.67%
10.8B
8.4B
-7.50% -58.73%
32.08
1.29
-4.27% -90.82%
MID-CAP
5.6B
929.6M
12.88% 30.87%
48.61
6
-1.74% 15.81%
5.3B
3.9B
-2.71% 37.34%
11.54
1.34
-8.19% 40.43%
4.1B
3.1B
1.92% 8.35%
38.56
1.3
-6.69% -83.51%
2.8B
3.0B
-3.00% 28.64%
8.58
0.93
-20.68% -74.38%
SMALL-CAP
1.2B
404.0M
0.11% 32.60%
36.59
3
24.06% -25.72%
701.0M
1.5B
13.21% -31.21%
308.42
0.48
-21.27% -97.94%
156.8M
336.4M
2.45% -24.28%
8.6
0.47
-12.92% 28.47%
48.0M
16.7M
-26.19% -67.37%
-3.21
3.05
-57.58% -734.07%
3.7M
-
-80.00% -99.58%
-0.01
0.01
- -

Balchem Corp News

Latest updates
Defense World7 hours ago
Defense World19 Jul 202405:15 am
American Banking and Market News16 Jul 202409:04 am
American Banking and Market News12 Jul 202405:29 am

Balchem Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue4.8%240229230231233233244237229213198202186181175173174167159162157
Cost Of Revenue2.9%158154153154159164176165157149137143127124119118119112105108108
Gross Profit8.7%82.0075.0077.0077.0073.0069.0068.0072.0072.0064.0061.0059.0059.0057.0056.0055.0055.0054.0054.0054.0049.00
Operating Expenses8.7%40.0037.0033.0035.0039.0035.0035.0032.0033.0030.0028.0029.0028.0028.0027.0028.0029.0031.0028.0028.0023.00
  S&GA Expenses-5.4%18.0019.0018.0019.0018.0018.0017.0016.0017.0015.0015.0015.0015.0015.0014.0014.0015.0016.0015.0015.0014.00
  R&D Expenses4.2%4.004.004.004.003.003.003.003.003.005.003.003.003.002.003.003.003.003.003.003.003.00
EBITDA Margin3.9%0.19*0.18*0.17*0.17*0.17*0.19*0.20*0.21*0.21*0.21*0.22*0.22*0.22*--------
Interest Expenses-2.0%-5.40-5.29-6.59-5.16-5.56-5.12-3.64-0.96-0.55-0.57-0.56-0.61-0.72-0.83-0.95-0.96-1.70-1.21-1.67-1.49-1.59
Income Taxes18.8%8.007.007.008.006.004.006.009.009.008.007.007.007.006.006.005.005.002.004.005.006.00
Earnings Before Taxes10.8%37.0033.0036.0038.0029.0026.0031.0039.0038.0033.0032.0030.0030.0028.0028.0026.0024.0022.0024.0025.0025.00
EBT Margin4.8%0.16*0.15*0.14*0.13*0.13*0.14*0.15*0.16*0.16*0.16*0.16*0.16*0.16*--------
Net Income8.8%29.0027.0029.0030.0023.0021.0025.0030.0029.0025.0025.0023.0023.0022.0022.0021.0020.0020.0021.0020.0019.00
Net Income Margin5.0%0.12*0.12*0.11*0.11*0.10*0.11*0.12*0.12*0.12*0.12*0.12*0.12*0.12*--------
Free Cashflow-50.5%33.0067.0040.0029.0029.0035.0035.0042.001.0038.0033.0030.0034.00--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-0.5%1,5891,5971,6031,6191,6291,6251,6331,6071,1951,1991,1791,1741,1691,1661,1611,1511,1621,1561,0971,098972
  Current Assets3.4%325314341337336336368377320322300287281267270264271255240232222
    Cash Equivalents-6.4%60.0064.0077.0067.0060.0067.0056.0076.0064.0010390.0080.0089.0085.0079.0076.0074.0066.0059.0042.0039.00
  Inventory0.8%11011011612512512013914110891.0082.0078.0077.0071.0077.0082.0083.0084.0074.0068.0067.00
  Net PPE-0.7%274276269271276271260252240238230228227228220217215217201204188
  Goodwill-0.9%772779767774774770749216523524525527526529526523523524504507446
Liabilities-6.1%510543578612655686737705321322290304320338342359396412363366261
  Current Liabilities-16.2%12414810811411714014214412414410510189.0094.0068.0068.0072.0092.0072.0062.0064.00
    LT Debt, Current------------------2.00---
Shareholder's Equity2.4%1,0791,0541,0251,007973938896901874877889870849828819793766744734732711
  Retained Earnings3.2%926897896867837814816791761732728703680657653632611591587567547
  Additional Paid-In Capital5.7%154146141137132129125121117148173173171165175174174174174170167
Shares Outstanding0.5%32.0032.0032.0032.0032.0032.0032.0032.0032.0032.0032.0032.00---------
Float----4,321---4,133---4,224---3,046---3,212-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-50.5%33,38867,40646,52634,99134,83841,65541,62048,2407,02144,49139,63435,78240,60747,95435,36044,61522,56532,96742,68226,32922,483
  Share Based Compensation25.5%4,7503,7853,7493,7484,7703,3862,9493,8123,0771,9932,8953,2922,6221,5482,2542,3202,1811,8792,0951,9911,631
Cashflow From Investing43.2%-6,739-11,865-9,276-3,611-10,061-14,489-85,113-306,340-10,072-14,181-7,599-7,294-6,226-13,211-7,787-8,199-5,394-53,1164,566-101,895-5,780
Cashflow From Financing57.2%-30,023-70,146-25,098-24,759-33,318-21,40128,386274,539-34,845-15,945-20,506-37,794-27,933-31,545-26,692-34,767-8,16025,760-28,66977,868-31,574
  Dividend Payments-25,555-3.002.0022,8675.004.001.0020,70319.004.00-18,7001.00--16,704---15,135
  Buy Backs1071.6%5,20244410175.003,84917846.0060034,59916,4777,9279,2391,5967,4812,9572,134891-20,594-727
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

BCPC Income Statement

2024-03-31
Condensed Consolidated Statements of Earnings - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Net sales$ 239,659$ 232,540
Cost of sales158,145159,370
Gross margin81,51473,170
Operating expenses:  
Selling expenses18,22718,183
Research and development expenses4,1003,450
General and administrative expenses17,51117,129
Total operating expenses39,83838,762
Earnings from operations41,67634,408
Other expenses, net:  
Interest expense, net5,3985,565
Other income, net(572)(276)
Total other (income) expenses4,8265,289
Earnings before income tax expense36,85029,119
Income tax expense7,8646,409
Net earnings$ 28,986$ 22,710
Net earnings per common share - basic (in dollars per share)$ 0.90$ 0.71
Net earnings per common share - diluted (in dollars per share)$ 0.89$ 0.70

BCPC Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 60,349$ 64,447
Accounts receivable, net of allowances of $997 and $908 at March 31, 2024 and December 31, 2023 respectively139,881125,284
Inventories, net110,381109,521
Prepaid expenses7,1227,798
Other current assets7,1267,192
Total current assets324,859314,242
Property, plant and equipment, net274,033276,039
Goodwill771,538778,907
Intangible assets with finite lives, net182,044191,212
Right of use assets - operating leases16,97317,763
Right of use assets - finance lease2,0372,101
Other non-current assets17,21616,947
Total assets1,588,7001,597,211
Current liabilities:  
Trade accounts payable59,79855,503
Accrued expenses37,77440,855
Accrued compensation and other benefits10,90217,228
Dividends payable6625,717
Income taxes payable11,8314,967
Operating lease liabilities - current3,7943,949
Finance lease liabilities - current260272
Total current liabilities124,425148,491
Revolving loan301,569309,569
Deferred income taxes51,00652,046
Operating lease liabilities - non-current13,97114,601
Finance lease liabilities - non-current1,8951,943
Other long-term obligations17,04316,577
Total liabilities509,909543,227
Commitments and contingencies (Note 15)
Stockholders' equity:  
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding00
Common stock, $0.0667 par value. Authorized 120,000,000 shares; 32,423,400 and 32,254,728 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively2,1632,152
Additional paid-in capital154,026145,653
Retained earnings926,474897,488
Accumulated other comprehensive (loss) income(3,872)8,691
Total stockholders' equity1,078,7911,053,984
Total liabilities and stockholders' equity$ 1,588,700$ 1,597,211
BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.
 CEO
 WEBSITEbalchem.com
 INDUSTRYChemicals
 EMPLOYEES1284

Balchem Corp Frequently Asked Questions


What is the ticker symbol for Balchem Corp? What does BCPC stand for in stocks?

BCPC is the stock ticker symbol of Balchem Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Balchem Corp (BCPC)?

As of Fri Jul 19 2024, market cap of Balchem Corp is 5.58 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers. The fair value of Balchem Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Balchem Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BCPC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Balchem Corp a good stock to buy?

The fair value guage provides a quick view whether BCPC is over valued or under valued. Whether Balchem Corp is cheap or expensive depends on the assumptions which impact Balchem Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BCPC.

What is Balchem Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 19 2024, BCPC's PE ratio (Price to Earnings) is 48.61 and Price to Sales (PS) ratio is 6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BCPC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Balchem Corp's stock?

In the past 10 years, Balchem Corp has provided 0.136 (multiply by 100 for percentage) rate of return.